- US-listed companies
- Park Ha Biological Technology Co., Ltd.
- Income statement
Park Ha Biological Technology Co., Ltd. (BYAH) Income statement
Market cap
P/E ratio
| 2024/10 | |
| Revenue | 2 |
| Cost of revenue | 195,336 |
| Gross profit | 2 |
| Gross margin (%) | |
| Research & development | 36,714 |
| Operating margin (%) | |
| Operating expenses | 1 |
| Operating income | 793,714 |
| Income before tax | 793,421 |
| Pretax margin (%) | 33.3 |
| Provision for income taxes | 314,860 |
| Effective tax rate (%) | |
| Net income | 478,561 |
| Net income margin (%) | |
| Earnings per share | 0.02 |
| Diluted EPS | 0.02 |